The effects of the angiotensin converting enzyme inhibitors benazepril (13), enalapril (E), and ramipril (R) on the function, geometry, and dimensions of the left ventricle (LV) in the dogs with naturally acquired severe mitral regurgitation (MR) were evaluated by echocardiography. Thirty-two dogs, aged 8-16 years and weighing 10-12 kg, with fractional shortening (FS) >50% were included into the Study. Benazepril (0.5mg/kg/d), enalapril (0.5mg/kg/d), and ramipril (0.5mg/kg/d) were administered orally to B, E, and R groups, respectively. Furosemide (2mg/kg/d) was administered orally for conventional heart failure therapy. Physical, radiographic, electrocardiographic, and echocardiographic examinations were performed before treatment and oil ...
The myxomatous mitral valve degeneration (DMVM) is the most common heart disease in dogs. The treatm...
Background—This study tested the hypothesis that 1-adrenoreceptor blockade modulates the angiotensin...
LV remodeling (enlargement, sphericity and myocyte hypertrophy), is a key process in the progressive...
Objectives.This study examined the effects of early long-term monotherapy with enalapril on the seve...
Severe degenetative myxomatous mitral valve disease (DMMVD) is a common condition in dogs. Therefore...
Background Recent clinical trials have suggested that ther-apy with angiotensin-converting enzyme in...
OBJECTIVE: Angiotensin II has been suggested to be involved in the pathogenesis of diastolic dysfunc...
Background and Objective: Sacubitril/valsartan (SV) is an angiotensin receptor-neprilysin inhibitor ...
Background: Pimobendan (PIMO) is a novel inodilator that has shown promising results in the treatmen...
AbstractObjectivesWe hypothesized that angiotensin II type-1 (AT1) receptor blocker (AT1RB) would pr...
Degenerative myxomatous mitral valve (DMMV) is a heart disease of high incidence in small animal cli...
AbstractObjectives. This study compared the effects of captopril and enalapril on left ventricular g...
AbstractObjectivesThe goal of this study was to determine the therapeutic efficacy of angiotensin-co...
Abstract Background Pimobendan, diuretics, and an angiotensin-converting enzyme inhibitor (ACEi) are...
Introduction: Efficacy of renin-angiotensin-aldosterone system (RAAS) blockade using angiotensin-con...
The myxomatous mitral valve degeneration (DMVM) is the most common heart disease in dogs. The treatm...
Background—This study tested the hypothesis that 1-adrenoreceptor blockade modulates the angiotensin...
LV remodeling (enlargement, sphericity and myocyte hypertrophy), is a key process in the progressive...
Objectives.This study examined the effects of early long-term monotherapy with enalapril on the seve...
Severe degenetative myxomatous mitral valve disease (DMMVD) is a common condition in dogs. Therefore...
Background Recent clinical trials have suggested that ther-apy with angiotensin-converting enzyme in...
OBJECTIVE: Angiotensin II has been suggested to be involved in the pathogenesis of diastolic dysfunc...
Background and Objective: Sacubitril/valsartan (SV) is an angiotensin receptor-neprilysin inhibitor ...
Background: Pimobendan (PIMO) is a novel inodilator that has shown promising results in the treatmen...
AbstractObjectivesWe hypothesized that angiotensin II type-1 (AT1) receptor blocker (AT1RB) would pr...
Degenerative myxomatous mitral valve (DMMV) is a heart disease of high incidence in small animal cli...
AbstractObjectives. This study compared the effects of captopril and enalapril on left ventricular g...
AbstractObjectivesThe goal of this study was to determine the therapeutic efficacy of angiotensin-co...
Abstract Background Pimobendan, diuretics, and an angiotensin-converting enzyme inhibitor (ACEi) are...
Introduction: Efficacy of renin-angiotensin-aldosterone system (RAAS) blockade using angiotensin-con...
The myxomatous mitral valve degeneration (DMVM) is the most common heart disease in dogs. The treatm...
Background—This study tested the hypothesis that 1-adrenoreceptor blockade modulates the angiotensin...
LV remodeling (enlargement, sphericity and myocyte hypertrophy), is a key process in the progressive...